EUVIMEDEUVIMED entdecken
Leserbrief

Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome

Elpida Phithak, Fredrik N Albach, Ioanna Minopoulou, Robert Biesen, Arnd Kleyer, Edgar Wiebe, Elise Siegert, Veronika Scholz, Marie Rehm, Qingyu Cheng, Arne Sattler, Stefano Bianco und 18 weitere

Annals of the Rheumatic Diseases · 2026-01 · 85 (1) · 212-215

DOI: 10.1016/j.ard.2025.09.012 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Annals of the Rheumatic Diseases, 2026-01. Verfasst von Elpida Phithak und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: German Research Foundation, European Union's Research and Innovation, Horizon 2020 Framework Programme.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibnitz Institute, Berlin, Germany.
  • German Rheumatism Research Centre (DRFZ) Berlin, a Leibnitz Institute, Berlin, Germany.
  • Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Rheumatology and Clinical Immunology, Immanuel Krankenhaus, Berlin, Germany.
  • Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13092 Berlin, Germany; German Cance…

Förderung

  • German Research Foundation
  • European Union's Research and Innovation
  • Horizon 2020 Framework Programme
  • European Commission

Zitieren

APA

Phithak, E., Albach, F. N., Minopoulou, I., Biesen, R., Kleyer, A., Wiebe, E., Siegert, E., Scholz, V., Rehm, M., Cheng, Q., Sattler, A., Bianco, S., Fleischmann, A., Hermann, K. G., Walter-Rittel, T., Wagner, M., Zernicke, J., Casteleyn, V., Nielsen, M., …, & Alexander, T. (2026). Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome. Annals of the Rheumatic Diseases, 85(1), 212-215. https://doi.org/10.1016/j.ard.2025.09.012

Vancouver

Phithak E, Albach FN, Minopoulou I, Biesen R, Kleyer A, Wiebe E, et al. Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome. Annals of the Rheumatic Diseases. 2026;85(1):212-215. doi:10.1016/j.ard.2025.09.012

BibTeX
@article{Phithak2026,
  author = {Phithak, Elpida and Albach, Fredrik N and Minopoulou, Ioanna and Biesen, Robert and Kleyer, Arnd and Wiebe, Edgar and Siegert, Elise and Scholz, Veronika and Rehm, Marie and Cheng, Qingyu and Sattler, Arne and Bianco, Stefano and Fleischmann, Anja and Hermann, Kay-Geert and Walter-Rittel, Thula and Wagner, Moritz and Zernicke, Jan and Casteleyn, Vincent and Nielsen, Martin and Rose, Thomas and Busse, Antonia and Hütter-Krönke, Marie Luise and Keller, Ulrich and Schneider, Udo and Kawelke, Leona and Ruffer, Nikolas and Stenzel, Werner and Krönke, Gerhard and Simon, David and Alexander, Tobias},
  title = {Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  volume = {85},
  number = {1},
  pages = {212--215},
  doi = {10.1016/j.ard.2025.09.012}
}
Kostenlos starten →